Our Pricing

Understanding Fatigue on Mounjaro: Causes, Comparisons and Solutions

Published on: June 03, 2026

Many UK patients report feeling tired on Mounjaro UK during the initial weeks of treatment, a side effect that typically resolves as your body adjusts to tirzepatide. At Cured Pharmacy, our clinical team helps patients understand why this fatigue occurs and how to manage it effectively throughout your weight loss journey.

Why Does Mounjaro Cause Tiredness?

Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that fundamentally changes how your body processes glucose and regulates appetite [1]. This metabolic shift can trigger temporary fatigue as your system adapts to lower calorie intake, altered blood sugar patterns, and changes in gastric emptying.

Clinical trials showed that tiredness affected approximately 8-12% of participants during dose escalation phases, though most cases were mild to moderate and self-limiting [1]. The fatigue typically stems from three interconnected factors: reduced caloric intake as appetite suppression takes effect, adjustment of insulin sensitivity and glucose metabolism, and gastrointestinal changes that may affect nutrient absorption.

Your body is essentially recalibrating its energy systems. The dual-hormone mechanism of tirzepatide means you're experiencing more pronounced metabolic changes than with single-pathway GLP-1 treatments, which can initially manifest as increased tiredness or reduced stamina [2].

Feeling Tired on Mounjaro vs Wegovy: Key Differences

Fatigue Profiles Compared

Whilst both Mounjaro and Wegovy can cause tiredness, the pattern and intensity differ due to their distinct mechanisms. Tirzepatide's dual-receptor action produces more rapid appetite suppression and metabolic changes, which may lead to more noticeable fatigue in the first 4-6 weeks [1][3].

Semaglutide (Wegovy) activates only GLP-1 receptors, resulting in a gentler metabolic transition for some patients. In comparative analyses, fatigue was reported by 8-12% of tirzepatide users versus 6-9% of semaglutide users during initial titration [3]. However, tirzepatide users also achieved greater average weight loss — 22.5% versus 14.9% at 72 weeks in head-to-head comparisons — suggesting the temporary fatigue may correlate with more substantial metabolic effects [1][2].

When Does Mounjaro Fatigue Typically Improve?

Most patients experience peak tiredness during the first 2-4 weeks after starting Mounjaro or increasing their dose. This corresponds with the period of most significant appetite suppression and metabolic adjustment. Clinical experience shows that energy levels typically stabilise within 6-8 weeks as your body adapts to the medication [1].

The gradual dose escalation protocol — starting at 2.5mg weekly and increasing every four weeks — is specifically designed to minimise side effects including fatigue. Patients who rush dose increases or skip titration steps often report more pronounced tiredness and other adverse effects.

If fatigue persists beyond 8-10 weeks or significantly impacts daily functioning, your UK prescriber may recommend maintaining your current dose longer before escalating, or investigating other potential causes such as nutritional deficiencies or thyroid function. All prescription adjustments require clinical assessment by a registered UK prescriber.

Practical Strategies to Manage Tiredness on Mounjaro

Nutrition and Hydration

Despite reduced appetite, maintaining adequate protein intake (1.2-1.6g per kilogram of body weight) is essential for preserving energy and muscle mass during weight loss. Focus on nutrient-dense foods even when eating smaller portions: lean proteins, leafy greens, whole grains, and healthy fats.

Dehydration amplifies fatigue significantly. Aim for at least 2-3 litres of water daily, increasing this if you're experiencing gastrointestinal side effects. Electrolyte balance is equally important — consider adding a pinch of salt to meals or using sugar-free electrolyte supplements if you're experiencing persistent tiredness.

How Other Weight Loss Treatments Compare for Energy Levels

Saxenda (liraglutide) requires daily injections and produces more gradual metabolic changes, which some patients find easier to tolerate from an energy perspective. However, its once-daily dosing means more frequent blood level fluctuations compared to Mounjaro's weekly administration [4].

Orlistat-based treatments like Xenical work through fat malabsorption rather than hormonal pathways, so they don't typically cause the same metabolic fatigue. However, they produce significantly less weight loss — averaging 5-8% versus up to 22.5% with tirzepatide — and carry different side effects related to fat excretion [1][5].

The newer oral semaglutide formulation (Wegovy tablets) may offer similar efficacy to injectable semaglutide with potentially different tolerability profiles, though long-term comparative data on fatigue specifically is still emerging. Your UK prescriber can assess which treatment aligns best with your medical history, lifestyle, and tolerance for temporary side effects.

When to Contact Your Prescriber About Mounjaro Fatigue

Warning Signs Requiring Clinical Review

Whilst mild to moderate tiredness is expected during Mounjaro initiation, certain symptoms warrant immediate clinical assessment. Contact your UK prescriber if you experience: severe fatigue that prevents daily activities, dizziness or fainting episodes, persistent headaches alongside tiredness, rapid heartbeat or palpitations, or fatigue accompanied by yellowing skin or eyes.

These symptoms may indicate complications requiring dose adjustment or further investigation. At Cured Pharmacy, our clinical team led by Superintendent Pharmacist Tarun Kumar (GPhC 2233073) provides ongoing support throughout your treatment. All patients have access to follow-up consultations if side effects become concerning or persistent beyond the expected adjustment period.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
3. Garvey, W. T., Frias, J. P., Jastreboff, A. M., et al. (2023). Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial. The Lancet, 402(10402), 613–626. https://doi.org/10.1016/S0140-6736(23)01200-X [accessed 13 August 2026]
4. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892 [accessed 13 August 2026]
5. Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155–161. https://doi.org/10.2337/diacare.27.1.155 [accessed 13 August 2026]
6. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
7. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
8. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.